Form 4: Bristol-Myers Squibb Exec's Stock Vesting & Tax Sale
Statement of Changes in Beneficial Ownership
Bristol-Myers Squibb EVP Gregory Scott Meyers reported the vesting of 6,281 restricted stock units and the sale of 2,665 shares for tax purposes.
Summary
- Gregory Scott Meyers, EVP, Chief Digital & Technology Officer at Bristol-Myers Squibb Co (BMY), reported changes in his beneficial ownership.
- On November 1, 2025, 6,281 restricted stock units (RSUs) vested, converting into an equal number of common stock shares.
- These vested RSUs represent one-third of the total RSUs granted on November 1, 2024.
- Concurrently, 2,665 shares of common stock were disposed of at a price of $46.07 per share to cover tax obligations related to the vesting.
- Following these transactions, Meyers directly beneficially owns 19,718 shares of common stock.
- Additionally, 12,562 derivative securities (restricted stock units) remain beneficially owned, which are scheduled to vest in two equal annual installments beginning November 1, 2026.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving the vesting of restricted stock units and subsequent tax-related share disposition, which is a neutral event for company performance.
Positives
- The vesting of 6,281 restricted stock units represents a realization of executive compensation, aligning management's interests with shareholder value over time.
Negatives
- The disposition of 2,665 shares, while for tax purposes, reduces the executive's direct beneficial ownership in the company.
Stakeholder Impact
- Shareholders: The transaction is a routine compensation event for an executive and is unlikely to have a significant direct impact on shareholders.
- Employees: No direct impact on general employees is indicated by this filing.
Next Steps
- The remaining 12,562 restricted stock units are scheduled to vest in two equal annual installments, beginning on November 1, 2026.
Key Dates
| Date | Description |
|---|---|
| 11/01/2024 | Date restricted stock units were granted to Gregory Scott Meyers. |
| 11/01/2025 | Date of transaction: Vesting of 6,281 restricted stock units and disposition of 2,665 shares for tax withholding. |
| 11/04/2025 | Date the Form 4 was signed by Lisa A. Atkins, attorney-in-fact for Gregory Scott Meyers. |
| 11/01/2027 | Expiration date for the remaining restricted stock units. |
Keywords
Bristol-Myers Squibb, BMY, Insider Transaction, Form 4, Stock Vesting, Executive Compensation, Restricted Stock Units, Share Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.